Edition:
United Kingdom

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

7.59USD
18 Apr 2019
Change (% chg)

$0.32 (+4.40%)
Prev Close
$7.27
Open
$7.21
Day's High
$7.59
Day's Low
$6.90
Volume
4,749
Avg. Vol
4,122
52-wk High
$10.57
52-wk Low
$3.66

About

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a... (more)

Overall

Beta: --
Market Cap(Mil.): $168.94
Shares Outstanding(Mil.): 13.88
Dividend: --
Yield (%): --

Financials

  ALPN.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -6.42 -- --
ROI: -48.40 8.91 13.83
ROE: -48.40 10.06 15.25

Earnings vs. Estimates